Sign in
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of DR Worsening Over Time: Results of DRCR Retina Network Protocol AA
Dennis M. Marcus, MD
Annual Meeting Talks
2022
Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
2023
Imaging, Digital, Angiography Symposium 2
2020
Category: Imaging